Literature DB >> 23493558

Preemptive priming readily overcomes structure-based mechanisms of virus escape.

Sophie A Valkenburg1, Stephanie Gras, Carole Guillonneau, Lauren A Hatton, Nicola A Bird, Kelly-Anne Twist, Hanim Halim, David C Jackson, Anthony W Purcell, Stephen J Turner, Peter C Doherty, Jamie Rossjohn, Katherine Kedzierska.   

Abstract

A reverse-genetics approach has been used to probe the mechanism underlying immune escape for influenza A virus-specific CD8(+) T cells responding to the immunodominant D(b)NP366 epitope. Engineered viruses with a substitution at a critical residue (position 6, P6M) all evaded recognition by WT D(b)NP366-specific CD8(+) T cells, but only the NPM6I and NPM6T mutants altered the topography of a key residue (His155) in the MHC class I binding site. Following infection with the engineered NPM6I and NPM6T influenza viruses, both mutations were associated with a substantial "hole" in the naïve T-cell receptor repertoire, characterized by very limited T-cell receptor diversity and minimal primary responses to the NPM6I and NPM6T epitopes. Surprisingly, following respiratory challenge with a serologically distinct influenza virus carrying the same mutation, preemptive immunization against these escape variants led to the generation of secondary CD8(+) T-cell responses that were comparable in magnitude to those found for the WT NP epitope. Consequently, it might be possible to generate broadly protective T-cell immunity against commonly occurring virus escape mutants. If this is generally true for RNA viruses (like HIV, hepatitis C virus, and influenza) that show high mutation rates, priming against predicted mutants before an initial encounter could function to prevent the emergence of escape variants in infected hosts. That process could be a step toward preserving immune control of particularly persistent RNA viruses and may be worth considering for future vaccine strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23493558      PMCID: PMC3619348          DOI: 10.1073/pnas.1302935110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes.

Authors:  Adrianus C M Boon; Gerrie de Mutsert; Debbie van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A.

Authors:  Julia R Gog; Guus F Rimmelzwaan; Albert D M E Osterhaus; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-03       Impact factor: 11.205

3.  Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope.

Authors:  Katherine Kedzierska; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

4.  Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.

Authors:  Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

5.  Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes.

Authors:  A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Rescue of influenza B virus from eight plasmids.

Authors:  Erich Hoffmann; Kutubuddin Mahmood; Chin-Fen Yang; Robert G Webster; Harry B Greenberg; George Kemble
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

7.  Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.

Authors:  Annette Oxenius; David A Price; Alexandra Trkola; Charles Edwards; Emma Gostick; Hua-Tang Zhang; Philippa J Easterbrook; Tin Tun; Andrew Johnson; Anele Waters; Edward C Holmes; Rodney E Phillips
Journal:  J Infect Dis       Date:  2004-07-20       Impact factor: 5.226

8.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

9.  Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.

Authors:  Alex T Chen; Markus Cornberg; Stephanie Gras; Carole Guillonneau; Jamie Rossjohn; Andrew Trees; Sebastien Emonet; Juan C de la Torre; Raymond M Welsh; Liisa K Selin
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

10.  Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.

Authors:  G E Price; R Ou; H Jiang; L Huang; D Moskophidis
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  12 in total

1.  Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles.

Authors:  Angela Pizzolla; Thi Ho Nguyen; Sneha Sant; Jade Jaffar; Tom Loudovaris; Stuart I Mannering; Paul G Thomas; Glen P Westall; Katherine Kedzierska; Linda M Wakim
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

2.  Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.

Authors:  Emma J Grant; Tracy M Josephs; Sophie A Valkenburg; Linda Wooldridge; Margaret Hellard; Jamie Rossjohn; Mandvi Bharadwaj; Katherine Kedzierska; Stephanie Gras
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

3.  Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes.

Authors:  Jonathan A Trujillo; Stephanie Gras; Kelly-Anne Twist; Nathan P Croft; Rudragouda Channappanavar; Jamie Rossjohn; Anthony W Purcell; Stanley Perlman
Journal:  J Immunol       Date:  2014-05-02       Impact factor: 5.422

4.  Altered Binding of Tumor Antigenic Peptides to MHC Class I Affects CD8+ T Cell-Effector Responses.

Authors:  Michael E Birnbaum; Stephanie K Dougan; Eleanor Clancy-Thompson; Christine A Devlin; Paul M Tyler; Mariah M Servos; Lestat R Ali; Katherine S Ventre; M Aladdin Bhuiyan; Patrick T Bruck
Journal:  Cancer Immunol Res       Date:  2018-10-23       Impact factor: 11.151

5.  Molecular basis for universal HLA-A*0201-restricted CD8+ T-cell immunity against influenza viruses.

Authors:  Sophie A Valkenburg; Tracy M Josephs; E Bridie Clemens; Emma J Grant; Thi H O Nguyen; George C Wang; David A Price; Adrian Miller; Steven Y C Tong; Paul G Thomas; Peter C Doherty; Jamie Rossjohn; Stephanie Gras; Katherine Kedzierska
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-31       Impact factor: 11.205

Review 6.  Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines.

Authors:  Saranya Sridhar
Journal:  Front Immunol       Date:  2016-05-19       Impact factor: 7.561

7.  Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice.

Authors:  Yongli Zhang; Hangjie Zhang; Wenqiang Ma; Kefang Liu; Min Zhao; Yingze Zhao; Xuancheng Lu; Fuping Zhang; Xiangdong Li; George F Gao; William J Liu
Journal:  J Vis Exp       Date:  2018-10-17       Impact factor: 1.355

8.  Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.

Authors:  Viraj Kulkarni; Antonio Valentin; Margherita Rosati; Candido Alicea; Ashish K Singh; Rashmi Jalah; Kate E Broderick; Niranjan Y Sardesai; Sylvie Le Gall; Beatriz Mothe; Christian Brander; Morgane Rolland; James I Mullins; George N Pavlakis; Barbara K Felber
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

9.  Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses.

Authors:  Gemma Hancock; Hongbing Yang; Elisabeth Yorke; Emma Wainwright; Victoria Bourne; Alyse Frisbee; Tamika L Payne; Mark Berrong; Guido Ferrari; Denis Chopera; Tomas Hanke; Beatriz Mothe; Christian Brander; M Juliana McElrath; Andrew McMichael; Nilu Goonetilleke; Georgia D Tomaras; Nicole Frahm; Lucy Dorrell
Journal:  PLoS Pathog       Date:  2015-02-27       Impact factor: 6.823

10.  Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.

Authors:  Martha Sedegah; Bjoern Peters; Michael R Hollingdale; Harini D Ganeshan; Jun Huang; Fouzia Farooq; Maria N Belmonte; Arnel D Belmonte; Keith J Limbach; Carter Diggs; Lorraine Soisson; Ilin Chuang; Eileen D Villasante
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.